195 related articles for article (PubMed ID: 22276118)
1. A novel, "double-clamp" binding mode for human heme oxygenase-1 inhibition.
Rahman MN; Vlahakis JZ; Vukomanovic D; Lee W; Szarek WA; Nakatsu K; Jia Z
PLoS One; 2012; 7(1):e29514. PubMed ID: 22276118
[TBL] [Abstract][Full Text] [Related]
2. X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode.
Rahman MN; Vlahakis JZ; Vukomanovic D; Szarek WA; Nakatsu K; Jia Z
J Med Chem; 2009 Aug; 52(15):4946-50. PubMed ID: 19601578
[TBL] [Abstract][Full Text] [Related]
3. X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors.
Rahman MN; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J Med Chem; 2008 Oct; 51(19):5943-52. PubMed ID: 18798608
[TBL] [Abstract][Full Text] [Related]
4. Structural characterization of human heme oxygenase-1 in complex with azole-based inhibitors.
Rahman MN; Vlahakis JZ; Roman G; Vukomanovic D; Szarek WA; Nakatsu K; Jia Z
J Inorg Biochem; 2010 Mar; 104(3):324-30. PubMed ID: 19917515
[TBL] [Abstract][Full Text] [Related]
5. Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone.
Roman G; Rahman MN; Vukomanovic D; Jia Z; Nakatsu K; Szarek WA
Chem Biol Drug Des; 2010 Jan; 75(1):68-90. PubMed ID: 19954435
[TBL] [Abstract][Full Text] [Related]
6. How does binding of imidazole-based inhibitors to heme oxygenase-1 influence their conformation? Insights combining crystal structures and molecular modelling.
Carletta A; Tilborg A; Moineaux L; de Ruyck J; Basile L; Salerno L; Romeo G; Wouters J; Guccione S
Acta Crystallogr B Struct Sci Cryst Eng Mater; 2015 Aug; 71(Pt 4):447-54. PubMed ID: 26208625
[TBL] [Abstract][Full Text] [Related]
7. Structural Insights into Azole-based Inhibitors of Heme Oxygenase-1: Development of Selective Compounds for Therapeutic Applications.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
Curr Med Chem; 2018; 25(42):5803-5821. PubMed ID: 30674243
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds.
Rahman MN; Vukomanovic D; Vlahakis JZ; Szarek WA; Nakatsu K; Jia Z
J R Soc Interface; 2013 Jan; 10(78):20120697. PubMed ID: 23097500
[TBL] [Abstract][Full Text] [Related]
9. X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase.
Sugishima M; Higashimoto Y; Oishi T; Takahashi H; Sakamoto H; Noguchi M; Fukuyama K
Biochemistry; 2007 Feb; 46(7):1860-7. PubMed ID: 17253780
[TBL] [Abstract][Full Text] [Related]
10. Structure-Activity Relationships of 1,2-Disubstituted Benzimidazoles: Selective Inhibition of Heme Oxygenase-2 Activity.
Kong X; Vukomanovic D; Nakatsu K; Szarek WA
ChemMedChem; 2015 Aug; 10(8):1435-41. PubMed ID: 26083133
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of imidazole-based compounds as heme oxygenase-1 inhibitors.
Sorrenti V; Guccione S; Di Giacomo C; Modica MN; Pittalà V; Acquaviva R; Basile L; Pappalardo M; Salerno L
Chem Biol Drug Des; 2012 Dec; 80(6):876-86. PubMed ID: 22882835
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of heme oxygenase-2 activity by analogs of 1-(4-chlorobenzyl)-2-(pyrrolidin-1-ylmethyl)-1H-benzimidazole (clemizole): Exploration of the effects of substituents at the N-1 position.
Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
Bioorg Med Chem; 2013 Nov; 21(21):6788-95. PubMed ID: 24021581
[TBL] [Abstract][Full Text] [Related]
13. Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region.
Floresta G; Fallica AN; Romeo G; Sorrenti V; Salerno L; Rescifina A; Pittalà V
Bioorg Chem; 2020 Nov; 104():104310. PubMed ID: 33010625
[TBL] [Abstract][Full Text] [Related]
14. Heme oxygenase inhibition by 1-aryl-2-(1h-imidazol-1-yl/1h-1,2,4-triazol-1-yl)ethanones and their derivatives.
Roman G; Vlahakis JZ; Vukomanovic D; Nakatsu K; Szarek WA
ChemMedChem; 2010 Sep; 5(9):1541-55. PubMed ID: 20652928
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the crystal structure and function to wild-type and His25Ala mutant human heme oxygenase-1.
Zhou WP; Zhong WW; Zhang XH; Ding JP; Zhang ZL; Xia ZW
Int J Mol Med; 2009 Mar; 23(3):379-87. PubMed ID: 19212657
[TBL] [Abstract][Full Text] [Related]
16. Isocyanides inhibit human heme oxygenases at the verdoheme stage.
Evans JP; Kandel S; Ortiz de Montellano PR
Biochemistry; 2009 Sep; 48(37):8920-8. PubMed ID: 19694439
[TBL] [Abstract][Full Text] [Related]
17. Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis.
Floresta G; Amata E; Dichiara M; Marrazzo A; Salerno L; Romeo G; Prezzavento O; Pittalà V; Rescifina A
ChemMedChem; 2018 Jul; 13(13):1336-1342. PubMed ID: 29693778
[TBL] [Abstract][Full Text] [Related]
18. A focus on heme oxygenase-1 (HO-1) inhibitors.
Pittalà V; Salerno L; Romeo G; Modica MN; Siracusa MA
Curr Med Chem; 2013; 20(30):3711-32. PubMed ID: 23746277
[TBL] [Abstract][Full Text] [Related]
19. Crystal structure of higher plant heme oxygenase-1 and its mechanism of interaction with ferredoxin.
Tohda R; Tanaka H; Mutoh R; Zhang X; Lee YH; Konuma T; Ikegami T; Migita CT; Kurisu G
J Biol Chem; 2021; 296():100217. PubMed ID: 33839679
[TBL] [Abstract][Full Text] [Related]
20. Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.
Salerno L; Pittalà V; Romeo G; Modica MN; Marrazzo A; Siracusa MA; Sorrenti V; Di Giacomo C; Vanella L; Parayath NN; Greish K
Eur J Med Chem; 2015; 96():162-72. PubMed ID: 25874340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
